These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 2917450)

  • 1. Nadolol in the treatment of aggressive behavior associated with schizophrenia.
    Ritrovato CA; Weber SS; Dufresne RL
    Clin Pharm; 1989 Feb; 8(2):132-5. PubMed ID: 2917450
    [No Abstract]   [Full Text] [Related]  

  • 2. The measurement of aggressive behavior: reflections on the use of the Overt Aggression Scale and the Modified Overt Aggression Scale.
    Ratey JJ; Gutheil CM
    J Neuropsychiatry Clin Neurosci; 1991; 3(2):S57-60. PubMed ID: 1821223
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of quetiapine on aggression and hostility in patients with schizophrenia.
    Arango C; Bernardo M
    Hum Psychopharmacol; 2005 Jun; 20(4):237-41. PubMed ID: 15830402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenergic blockers for aggressive behavior in schizophrenia.
    Am J Psychiatry; 1987 Apr; 144(4):538-9. PubMed ID: 2882699
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment of impulsive and aggressive behavior with nadolol.
    Polakoff SA; Sorgi PJ; Ratey JJ
    J Clin Psychopharmacol; 1986 Apr; 6(2):125-6. PubMed ID: 3700702
    [No Abstract]   [Full Text] [Related]  

  • 6. Nadolol in the treatment of aggression in chronic psychiatric inpatients.
    Wong MK; Lee S
    J Clin Psychiatry; 1993 Jun; 54(6):235. PubMed ID: 8331093
    [No Abstract]   [Full Text] [Related]  

  • 7. Aggression and schizophrenia: efficacy of risperidone.
    Buckley PF; Ibrahim ZY; Singer B; Orr B; Donenwirth K; Brar PS
    J Am Acad Psychiatry Law; 1997; 25(2):173-81. PubMed ID: 9213289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of aggressive behavior and quality of life impairment following S-adenosyl-methionine (SAM-e) augmentation in schizophrenia.
    Strous RD; Ritsner MS; Adler S; Ratner Y; Maayan R; Kotler M; Lachman H; Weizman A
    Eur Neuropsychopharmacol; 2009 Jan; 19(1):14-22. PubMed ID: 18824331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggression and psychopathology in treatment-resistant inpatients with schizophrenia and schizoaffective disorder.
    Nolan KA; Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome LL; McEvoy J; Lieberman JA
    J Psychiatr Res; 2005 Jan; 39(1):109-15. PubMed ID: 15504429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eltoprazine in aggressive mentally handicapped patients: a double-blind, placebo- and baseline-controlled multi-centre study. The Eltoprazine Aggression Research Group.
    de Koning P; Mak M; de Vries MH; Allsopp LF; Stevens RB; Verbruggen R; Van den Borre R; van Peteghem P; Kohen D; Arumainayagam M
    Int Clin Psychopharmacol; 1994 Sep; 9(3):187-94. PubMed ID: 7814828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: A preliminary study.
    Abecasis R; Kravetz D; Fassio E; Ameigeiras B; Garcia D; Isla R; Landeira G; Dominguez N; Romero G; Argonz J; Terg R
    Hepatology; 2003 Feb; 37(2):359-65. PubMed ID: 12540786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind study of tybamate in psychotic patients.
    Meshel E; Denber HC
    Dis Nerv Syst; 1967 May; 28(5):311-3. PubMed ID: 5338174
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of parenteral loxapine and haloperidol in hostile and aggressive acutely schizophrenic patients.
    Tuason VB
    J Clin Psychiatry; 1986 Mar; 47(3):126-9. PubMed ID: 3512535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Violence among schizophrenia out-patients compliant with medication: prevalence and associated factors.
    Bobes J; Fillat O; Arango C
    Acta Psychiatr Scand; 2009 Mar; 119(3):218-25. PubMed ID: 19178395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Violence and schizophrenia: clozapine as a specific antiaggressive agent.
    Buckley P; Bartell J; Donenwirth K; Lee S; Torigoe F; Schulz SC
    Bull Am Acad Psychiatry Law; 1995; 23(4):607-11. PubMed ID: 8639988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paliperidone extended-release tablets for prevention of symptom recurrence in patients with schizophrenia: a randomized, double-blind, placebo-controlled study.
    Kramer M; Simpson G; Maciulis V; Kushner S; Vijapurkar U; Lim P; Eerdekens M
    J Clin Psychopharmacol; 2007 Feb; 27(1):6-14. PubMed ID: 17224706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is treatment with nadolol effective against the growth of small esophageal varices in patients with cirrhosis?
    Bosch J
    Nat Clin Pract Gastroenterol Hepatol; 2005 Jan; 2(1):18-9. PubMed ID: 16265094
    [No Abstract]   [Full Text] [Related]  

  • 19. Nadolol and placebo comparison study in the prophylactic treatment of migraine.
    Ryan RE; Ryan RE; Sudilovsky A
    Panminerva Med; 1982; 24(2):89-94. PubMed ID: 6128710
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of anticonvulsants in the treatment of impulsive aggression.
    Stanford MS; Helfritz LE; Conklin SM; Villemarette-Pittman NR; Greve KW; Adams D; Houston RJ
    Exp Clin Psychopharmacol; 2005 Feb; 13(1):72-7. PubMed ID: 15727506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.